NCT01210352 - Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 13, 2010

Primary Completion Date

October 6, 2017

Study Completion Date

October 6, 2017

Conditions

Post Operative Pain

Interventions

DRUG

oxymorphone HCl

Comparison of different dosages of drug, 0.05mg/kg, 0.10mg/kg, 0.15mg/kg or 0.20mg/kg oral liquid oxymorphone

Trial Locations (8)

Endo Clinical Trial Site #12, Pittsburgh

Endo Clinical Trial Site #13, Nashville

Endo Clinical Trial Site #6, Indianapolis

Endo Clinical Trial Site #1, Little Rock

Endo Clinical Trial Site #11, Oklahoma City

Endo Clinical Trial Site #14, Dallas

Endo Clinical Trial Site #3, Aurora

Endo Clinical Trial Site #19, Tucson